Activation of small GTPase Rho is required for autocrine motility factor signaling
- PMID: 12154059
Activation of small GTPase Rho is required for autocrine motility factor signaling
Abstract
The hallmark of tumor metastasis is the dissemination of cells from the primary growth site to distant organs. Autocrine motility factor (AMF), a tumor-associated C-X-X-C cytokine, the ligand for a unique 78 kDa seven transmembrane receptor, is a potent simulator of cell motility, a process that is a prerequisite for tumor progression and metastasis. Because little is known about AMF-dependent signaling, we sought to study whether AMF signaling involves family members of the Rho-like GTPases. AMF stimulation of human melanoma cells resulted in stress-fiber formation, concomitant with up-regulation and activation of both RhoA and Rac1 expression with no apparent changes in the expression level or activation state of Cdc42. Treatment of the cells with C3 exoenzyme before AMF stimulation inhibited both the formation of stress-fiber-like structures and the activation of RhoA. In addition, both c-Jun NH(2)-terminal kinase 1 and c-Jun NH(2)-terminal kinase 2 were simultaneously activated by AMF, supporting the notion that they are involved in the signaling pathway of RhoA. We thus conclude that AMF signaling shares a similar pathway to previously established paracrine factors signaling involving cytoskeletal rearrangement and morphological alterations mediated by the small RhoA-like GTPases.
Similar articles
-
Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy.Endocr Relat Cancer. 2004 Dec;11(4):749-59. doi: 10.1677/erc.1.00811. Endocr Relat Cancer. 2004. PMID: 15613449 Review.
-
Differential role of Rho GTPases in intestinal epithelial barrier regulation in vitro.J Cell Physiol. 2011 May;226(5):1196-203. doi: 10.1002/jcp.22446. J Cell Physiol. 2011. PMID: 20945370
-
Rho guanosine 5'-triphosphatases differentially regulate insulin-like growth factor I (IGF-I) receptor-dependent and -independent actions of IGF-II on human trophoblast migration.Endocrinology. 2007 Oct;148(10):4906-17. doi: 10.1210/en.2007-0476. Epub 2007 Jul 19. Endocrinology. 2007. PMID: 17640993
-
DEF6, a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA.Exp Cell Res. 2004 Apr 1;294(2):335-44. doi: 10.1016/j.yexcr.2003.12.004. Exp Cell Res. 2004. PMID: 15023524
-
The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase.Mol Biosyst. 2009 Aug;5(8):793-801. doi: 10.1039/b820820b. Epub 2009 May 29. Mol Biosyst. 2009. PMID: 19603112 Review.
Cited by
-
How does cancer cell metabolism affect tumor migration and invasion?Cell Adh Migr. 2013 Sep-Oct;7(5):395-403. doi: 10.4161/cam.26345. Epub 2013 Oct 8. Cell Adh Migr. 2013. PMID: 24131935 Free PMC article. Review.
-
Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma.PLoS One. 2014 Apr 15;9(4):e95171. doi: 10.1371/journal.pone.0095171. eCollection 2014. PLoS One. 2014. PMID: 24736611 Free PMC article.
-
Evidence for Recombinant GRP78, CALR, PDIA3 and GPI as Mediators of Genetic Instability in Human CD34+ Cells.Cancers (Basel). 2022 Jun 11;14(12):2883. doi: 10.3390/cancers14122883. Cancers (Basel). 2022. PMID: 35740549 Free PMC article.
-
Gp78 E3 Ubiquitin Ligase: Essential Functions and Contributions in Proteostasis.Front Cell Neurosci. 2017 Aug 25;11:259. doi: 10.3389/fncel.2017.00259. eCollection 2017. Front Cell Neurosci. 2017. PMID: 28890687 Free PMC article. Review.
-
Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy.Biochim Biophys Acta. 2008 Dec;1786(2):87-104. doi: 10.1016/j.bbcan.2008.07.002. Epub 2008 Jul 22. Biochim Biophys Acta. 2008. PMID: 18692117 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials
Miscellaneous